首页|期刊导航|中国人兽共患病学报|结核分枝杆菌B/R菌株灭活全菌裂解液的制备及其免疫原性与安全性评价

结核分枝杆菌B/R菌株灭活全菌裂解液的制备及其免疫原性与安全性评价OA

Preparation,immunogenicity,and safety of inactivated whole-cell lysate of the Mycobacterium tuberculosis B/R strain

中文摘要英文摘要

目的 利用超声微气泡物理损伤技术联合酶解法(溶菌酶/甘氨酸),灭活新型结核杆菌融合菌株(简称B/R菌株),制备安全高效的新型结核杆菌融合菌株灭活全菌裂解液(简称UK-B/R),并评估其灭活效果、关键结核抗原保留、免疫原性及安全性等.方法 利用超声微气泡物理损伤技术(超声微气泡破碎30 min),联合溶菌酶-甘氨酸预处理(6 h),灭活B/R菌株.通过菌落培养、FDA酯酶活性流式检测及N01/PI荧光染色等验证灭活效果.Western blot检测灭活处理对结核特异性抗原(ESAT6、CFP10、MPT64、Ag85B)的影响.通过皮下免疫C57BL/6J小鼠(分PBS组、BCG组、B/R组、UK-B/R组),免疫后第2周和第4周,分别用ELISA检测各组小鼠血清细胞因子(IFN-γ、TNF-α、IL-2)及血清特异性抗体.CCK-8法分析UK-B/R对RAW 264.7巨噬细胞的毒性.结果 菌落培养、细菌酯酶活性检测及荧光染色均证实B/R菌株灭活完全.Western blot检测结果显示B/R菌株灭活前后均含有ESAT6/CFP10(11 kDa)、MPT64(25 kDa)、Ag85B(37 kDa)等关键结核抗原.UK-B/R皮下免疫后,可诱导较高水平的细胞因子,其诱导的细胞因子表达呈时间动态变化及性别差异性,同时诱导血清中产生高水平的特异性IgG.此外,UK-B/R免疫后小鼠无不良反应.体外实验结果显示,不同剂量UK-B/R对巨噬细胞活力无影响.结论 利用超声微气泡物理损伤技术联合酶解法制备的UK-B/R,灭活彻底、保留关键结核抗原,可有效激活细胞免疫应答及体液免疫应答,且安全性良好,具备作为候选结核病灭活全菌疫苗的潜力.

This study was aimed at developing a safe and effective inactivated whole-cell lysate of a novel Mycobacterium tubercu-losis(M.tb)fusion strain(B/R strain)by using ultrasonic microbubble cavitation combined with enzymatic lysis(lysozyme/glycine),hereafter referred to as the ultrasonically-killed B/R strain(UK-B/R).Inactivation efficacy,preservation of conformational epitopes,immunogenicity,and safety were systematically evaluated.The B/R strain was inactivated with ultrasonic microbubble cavitation(30 minutes)combined with pretreatment with lysozyme-glycine(6 hours).The inactivation was verified through colony culture,flow cyto-metric analysis of FDA esterase activity,and N01/PI fluorescence staining.The effects of the inactivation process on key M.tb anti-genic proteins(ESAT6,CFP10,MPT64,and Ag85B)were assessed with western blotting.C57BL/6J mice were subcutaneously im-munized and divided into four groups:PBS,BCG,B/R,and UK-B/R.At weeks 2 and 4 post-immunization,serum cytokines(IFN-γ,TNF-α,and IL-2)and antigen-specific antibodies were measured with ELISA.The cytotoxicity of UK-B/R toward RAW 264.7 macrophages was analyzed with CCK-8 assays.Culture colony assays,bacterial esterase activity tests,and fluorescence staining to-gether confirmed the complete inactivation of the B/R strain.Western blot analysis indicated that the B/R strain retained key tuberculo-sis antigens such as ESAT6/CFP10(11 kDa),MPT64(25 kDa),and Ag85B(37 kDa)both before and after inactivation.Subcutane-ous immunization with UK-B/R induced high levels of cytokines,whose expression showed time-dependent dynamics and sex-specific differences,and elicited high levels of antigen-specific IgG in serum.Furthermore,no adverse reactions were observed in mice immunized with UK-B/R.In vitro experiments demonstrated that various doses of UK-B/R had no effects on macrophage viabil-ity.This study demonstrated that UK-B/R,prepared by ultrasonic microbubble cavitation combined with enzymatic lysis,demon-strated complete inactivation,preserved critical mycobacterial antigens,effectively activated both cellular and humoral immune re-sponses,and exhibited a favorable safety profile.Therefore,this strain has potential as a candidate inactivated whole-cell vaccine against tuberculosis.

盘智敏;章乐;张万江;徐梅;徐锋;李晓梅;董江涛;张杰;吴芳;梁粟;柳小玲

石河子大学医学院病理生理学教研室/新疆地方与民族高发病教育部重点实验室,石河子 832002石河子大学医学院病理生理学教研室/新疆地方与民族高发病教育部重点实验室,石河子 832002石河子大学医学院病理生理学教研室/新疆地方与民族高发病教育部重点实验室,石河子 832002石河子大学第一附属医院,石河子 832003杭州市萧山区第一人民医院,杭州 311200昌吉回族自治州人民医院,昌吉 831199石河子大学第一附属医院,石河子 832003石河子大学第一附属医院,石河子 832003石河子大学医学院病理生理学教研室/新疆地方与民族高发病教育部重点实验室,石河子 832002石河子大学第一附属医院,石河子 832003石河子大学医学院病理生理学教研室/新疆地方与民族高发病教育部重点实验室,石河子 832002

医药卫生

新型结核杆菌融合菌株(B/R菌株)灭活全菌疫苗超声微气泡物理损伤技术酶解法免疫原性

novel Mycobacterium tuberculosis fusion strain(B/R strain)inactivated whole-cell vaccineultrasonic microbubble cavitationenzymatic lysisimmunogenicity

《中国人兽共患病学报》 2026 (4)

348-355,8

2023年兵团重点领域科技攻关计划项目(No.2023AB053)国家自然科学基金资助项目(No.82360321)2022年兵团指导性科技计划项目(No.2022ZD043). Key Field Science and Technology Research and Development Program Project of the Xinjiang Production and Con-struction Corps(No.2023AB053)National Natural Science Foundation of China(No.82360321)Corps Guiding Science and Tech-nology Plan Project(No.2022ZD043).

10.3969/j.issn.1002-2694.2026.00.025

评论